| Intrinsic Valuation of: CHKP | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 8 | Market Cap | $24B | |||||
| 2021 | - | - (-) | P/E Ratio | 29 | Total Asset | $6B | |||||
| 2022 | $1B | - (-) | Net Income | $846M | Total Debt | $0 | |||||
| 2023 | $1B | -9.4% (-15.7%) | EBITDA | $1B | Total Liab | $3B | |||||
| 2024 | $1B | -5.3% (-8.6%) | Opr Margin | 0.34 | Debt/Equity | - | |||||
| 2025 | $1B | 0.9% (-5.0%) | PreTax Margin | 34.08 | BV/Share | 8 | |||||
| 5Y Average FCF | $1B | -4.6% (-9.8%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (4.0%) | ||||||||||
| 2026 | $1B | MBG Intrinsic Value | $68 | ||||||||
| 2027 | $1B | ||||||||||
| 2028 | $1B | ||||||||||
| 2029 | $1B | ||||||||||
| 2030 | $1B | ||||||||||
| 2031 | $1B | ||||||||||
| Terminal Value | $27B | Net Worth/Share | $26 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $23B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $506M | $218 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $0 | WACC | 7.3% | 192 | 206 | 222 | 243 | 268 | |||
| Equity Value | $24B | 7.4% | 191 | 204 | 220 | 240 | 265 | ||||
| Shares Outstanding | 108,369,000 | 7.4% | 189 | 202 | 218 | 237 | 261 | ||||
| 7.9% | 175 | 185 | 198 | 213 | 232 | ||||||
| DCF Intrinsic Value | $218 | 8.4% | 162 | 171 | 182 | 194 | 209 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||